Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Janssen letter to DGHS on bedaquiline


Published on

Letter dt. 28 May 2014 from Sanjiv Navangul, MD Janssen India to Dr. Jagdish Prasad, Director-General of Health Services, Ministry of Health and Family Welfare requesting a reconsideration of the New Drug Advisory Committee's decision to deny Janssen a waiver of Phase III trials in respect of bedaquiline.

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this